Literature DB >> 29632329

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.

Quirin Hammer1, Timo Rückert1, Eva Maria Borst2, Josefine Dunst3, André Haubner1, Pawel Durek4,5, Frederik Heinrich6, Gilles Gasparoni7, Marina Babic1, Adriana Tomic2, Gabriella Pietra8,9, Mikalai Nienen10, Igor Wolfgang Blau11, Jörg Hofmann12,13, Il-Kang Na11,14,15, Immo Prinz16, Christian Koenecke16,17, Philipp Hemmati11, Nina Babel10,18, Renate Arnold11, Jörn Walter7, Kevin Thurley19, Mir-Farzin Mashreghi6, Martin Messerle2, Chiara Romagnani20,21.   

Abstract

Natural killer (NK) cells are innate lymphocytes that lack antigen-specific rearranged receptors, a hallmark of adaptive lymphocytes. In some people infected with human cytomegalovirus (HCMV), an NK cell subset expressing the activating receptor NKG2C undergoes clonal-like expansion that partially resembles anti-viral adaptive responses. However, the viral ligand that drives the activation and differentiation of adaptive NKG2C+ NK cells has remained unclear. Here we found that adaptive NKG2C+ NK cells differentially recognized distinct HCMV strains encoding variable UL40 peptides that, in combination with pro-inflammatory signals, controlled the population expansion and differentiation of adaptive NKG2C+ NK cells. Thus, we propose that polymorphic HCMV peptides contribute to shaping of the heterogeneity of adaptive NKG2C+ NK cell populations among HCMV-seropositive people.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29632329     DOI: 10.1038/s41590-018-0082-6

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  124 in total

Review 1.  Conserved and variable natural killer cell receptors: diverse approaches to viral infections.

Authors:  Leidy Y Bastidas-Legarda; Salim I Khakoo
Journal:  Immunology       Date:  2019-01-17       Impact factor: 7.397

2.  Adaptive NK cell reconstitution is associated with better clinical outcomes.

Authors:  Frank Cichocki; Emily Taras; Flavia Chiuppesi; John E Wagner; Bruce R Blazar; Claudio Brunstein; Xianghua Luo; Don J Diamond; Sarah Cooley; Daniel J Weisdorf; Jeffrey S Miller
Journal:  JCI Insight       Date:  2019-01-24

Review 3.  Adaptive NK cell responses in HIV/SIV infections: A roadmap to cell-based therapeutics?

Authors:  Daniel R Ram; Cordelia Manickam; Olivier Lucar; Spandan V Shah; R Keith Reeves
Journal:  J Leukoc Biol       Date:  2019-02-07       Impact factor: 4.962

4.  Cytomegalovirus Infection Drives Avidity Selection of Natural Killer Cells.

Authors:  Nicholas M Adams; Clair D Geary; Endi K Santosa; Dianne Lumaquin; Jean-Benoît Le Luduec; Rosa Sottile; Kattria van der Ploeg; Joy Hsu; Benjamin M Whitlock; Benjamin T Jackson; Orr-El Weizman; Morgan Huse; Katharine C Hsu; Joseph C Sun
Journal:  Immunity       Date:  2019-05-15       Impact factor: 31.745

Review 5.  Clonal expansion of innate and adaptive lymphocytes.

Authors:  Nicholas M Adams; Simon Grassmann; Joseph C Sun
Journal:  Nat Rev Immunol       Date:  2020-05-18       Impact factor: 53.106

6.  The IL-12- and IL-23-Dependent NK Cell Response Is Essential for Protective Immunity against Secondary Toxoplasma gondii Infection.

Authors:  Daria L Ivanova; Tiffany M Mundhenke; Jason P Gigley
Journal:  J Immunol       Date:  2019-10-11       Impact factor: 5.422

7.  Polarized mitochondria as guardians of NK cell fitness.

Authors:  Laura Surace; Jean-Marc Doisne; Pedro Escoll; Solenne Marie; Valerie Dardalhon; Carys Croft; Anna Thaller; Davide Topazio; Angelo Sparaneo; Antonia Cama; Olimpia Musumeci; Aurelio d'Ecclesia; Carmen Buchrieser; Naomi Taylor; James P Di Santo
Journal:  Blood Adv       Date:  2021-01-12

8.  Murine Cytomegalovirus M25 Proteins Sequester the Tumor Suppressor Protein p53 in Nuclear Accumulations.

Authors:  Martina Dezeljin; Martin Messerle; Ivana Kutle; Katarzyna M Szymańska-de Wijs; Boris Bogdanow; Berislav Cuvalo; Lars Steinbrück; Stipan Jonjić; Karen Wagner; Rainer Niedenthal; Matthias Selbach; Lüder Wiebusch
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

9.  Simian Immunodeficiency Virus Infection Modulates CD94+ (KLRD1+) NK Cells in Rhesus Macaques.

Authors:  Daniel R Ram; Olivier Lucar; Brady Hueber; R Keith Reeves
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

Review 10.  The cancer-natural killer cell immunity cycle.

Authors:  Nicholas D Huntington; Joseph Cursons; Jai Rautela
Journal:  Nat Rev Cancer       Date:  2020-06-24       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.